Saudubray J-M, Sedel F, Walter J H
Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker Enfants-Malades, Université René Descartes, 149 rue de Sèvres, 75743, Paris Cedex 15, France.
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):261-74. doi: 10.1007/s10545-006-0358-0.
In view of the major improvements in treatment, it has become increasingly important that in order for first-line physicians not to miss a treatable disorder they should be able initiate a simple method of clinical screening, particularly in the emergency room. We present a simplified classification of treatable inborn errors of metabolism in three groups. Group 1 includes inborn errors of intermediary metabolism that give rise to an acute or chronic intoxication. It encompasses aminoacidopathies, organic acidurias, urea cycle disorders, sugar intolerances, metal disorders and porphyrias. Clinical expression can be acute or systemic or can involve a specific organ, and can strike in the neonatal period or later and intermittently from infancy to late adulthood. Most of these disorders are treatable and require the emergency removal of the toxin by special diets, extracorporeal procedures, cleansing drugs or vitamins. Group 2 includes inborn errors of intermediary metabolism that affect the cytoplasmic and mitochondrial energetic processes. Cytoplasmic defects encompass those affecting glycolysis, glycogenosis, gluconeogenesis, hyperinsulinisms, and creatine and pentose phosphate pathways; the latter are untreatable. Mitochondrial defects include respiratory chain disorders, and Krebs cycle and pyruvate oxidation defects, mostly untreatable, and disorders of fatty acid oxidation and ketone bodies that are treatable. Group 3 involves cellular organelles and includes lysosomal, peroxisomal, glycosylation, and cholesterol synthesis defects. Among these, some lysosomal disorders can be efficiently treated by enzyme replacement or substrate reduction therapies. Physicians can be faced with the possibility of a treatable inborn error in an emergency, either in the neonatal period or late in infancy to adulthood, or as chronic and progressive symptoms--general (failure to thrive), neurological, or specific for various organs or systems. These symptoms are summarized in four tables. In addition, an extensive list of medications used in the treatment of inborn errors is presented.
鉴于治疗方面的重大进展,一线医生为了不遗漏可治疗的疾病,应能够启动一种简单的临床筛查方法,这一点变得越来越重要,尤其是在急诊室。我们提出了一种将可治疗的先天性代谢缺陷简化为三组的分类方法。第一组包括导致急性或慢性中毒的中间代谢先天性缺陷。它包括氨基酸病、有机酸尿症、尿素循环障碍、糖不耐受、金属紊乱和卟啉病。临床表现可以是急性的或全身性的,也可以涉及特定器官,可以在新生儿期或以后发病,从婴儿期到成年后期呈间歇性发作。这些疾病大多是可治疗的,需要通过特殊饮食、体外程序、解毒药物或维生素紧急清除毒素。第二组包括影响细胞质和线粒体能量过程的中间代谢先天性缺陷。细胞质缺陷包括影响糖酵解、糖原病、糖异生、高胰岛素血症以及肌酸和磷酸戊糖途径的缺陷;后者是不可治疗的。线粒体缺陷包括呼吸链障碍、三羧酸循环和丙酮酸氧化缺陷,大多不可治疗,以及可治疗的脂肪酸氧化和酮体紊乱。第三组涉及细胞器,包括溶酶体、过氧化物酶体、糖基化和胆固醇合成缺陷。其中,一些溶酶体疾病可以通过酶替代或底物减少疗法得到有效治疗。医生在急诊时可能会面对可治疗的先天性代谢缺陷的可能性,无论是在新生儿期,还是在婴儿后期到成年期,或者是作为慢性和进行性症状——一般症状(发育不良)、神经症状,或针对各种器官或系统的特定症状。这些症状总结在四张表格中。此外,还列出了用于治疗先天性代谢缺陷的大量药物清单。